The DOI matches its Crossref record; 244 of the 244 references it cites were found in a registry or an index.
Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment
Open accessAbstract
The term "lipid" is used to identify a large set of hydrophobic and amphiphilic molecules such as free fatty acids, sterols, fatty acid esters, and phospholipids.These molecules are involved in forming fundamental structures in cells and tissues, providing energy for the metabolic needs of organisms, and regulating several homeostatic processes within and outside of cells, including organelle homeostasis, immune function, inter-organ communication, energy metabolism, and cell survival.However, when the balance in their metabolism and composition is altered by environmental or metabolic stress, lifestyle, and genetic or epigenetic factors, lipids can also become critical components of pathophysiological cascades that are detrimental to healthy cell and tissue function.Hence, although lipids play fundamental physiological roles, in excess or in improper composition, they can be highly damaging, leading to organelle dysfunction, cell death, chronic inflammation, and disturbances in energy and substrate metabolism and survival responses.In this review, we primarily focus on the roles of lipid classes that regulate immune responses and signaling mechanisms, which perpetuate a vicious cycle of metabolic and inflammatory disturbances leading to disease.Abstract Lipids encompass a wide variety of molecules such as fatty acids, sterols, phospholipids, and triglycerides.These molecules represent a highly efficient energy resource and can act as structural elements of membranes or as signaling molecules that regulate metabolic homeostasis through many mechanisms.Cells possess an integrated set of response systems to adapt to stresses such as those imposed by nutrient fluctuations during feeding-fasting cycles.While lipids are pivotal for these homeostatic processes, they can also contribute to detrimental metabolic outcomes.When metabolic stress becomes chronic and adaptive mechanisms are overwhelmed, as occurs during prolonged nutrient excess or obesity, lipid influx can exceed the adipose tissue storage capacity and result in accumulation of harmful lipid species at ectopic sites such as liver and muscle.As lipid metabolism and immune responses are highly integrated, accumulation of harmful lipids or generation of signaling intermediates can interfere with immune regulation in multiple tissues, causing a vicious cycle of immune-metabolic dysregulation.In this review, we summarize the role of lipotoxicity in metaflammation at the molecular and tissue level, describe the significance of anti-inflammatory lipids in metabolic homeostasis, and discuss the potential of therapeutic approaches targeting pathways at the intersection of lipid metabolism and immune function.-ErikciErtunc, M., and G. S. Hotamisligil.Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment.J. Lipid Res.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–244 of 244
Takada, Y., Ichikawa, H., Pataer, A., Swisher, S. G., & Aggarwal, B. B. (2006) · Oncogene · doi:10.1038/sj.onc.1209906 · Cited by 112
Talbot, N. A., Wheeler-Jones, C. P. D., & Cleasby, M. E. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.06.010 · Cited by 110
Furuhashi, M., Ishimura, S., Ota, H., Hayashi, M., Nishitani, T., Tanaka, M., Yoshida, H., Shimamoto, K., Hotamışlıgil, G. S., & Miura, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027356 · Cited by 105
Burak, M. F., Inouye, K., White, A., Lee, A., Tuncman, G., Calay, E. S., Sekiya, M., Tirosh, A., Eguchi, K., Birrane, G., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac6336 · Cited by 104
High fat diet induced diabetic cardiomyopathy
Dirkx, E., Schwenk, R. W., Glatz, J. F. C., Luiken, J. J. F. P., & van Eys, G. J. J. M. (2011) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.04.018 · Cited by 102
Dong, B., Qi, D., Yang, L., Huang, Y., Xiao, X., Tai, N., Li, W., & Wong, F. S. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00948.2011 · Cited by 97
Mita, T., Furuhashi, M., Hiramitsu, S., Ishii, J., Hoshina, K., Ishimura, S., Fuseya, T., Watanabe, Y. S., Tanaka, M., Ohno, K., et al. (2014) · Obesity · doi:10.1002/oby.20954 · Cited by 96
Liang, H., Yin, B., Zhang, H., Zhang, S., Zeng, Q., Wang, J., Jiang, X., Li, Y., Wang, C., & Li, Z. (2008) · Endocrinology · doi:10.1210/en.2007-0978 · Cited by 94
Zhao, L., Chen, Y., Tang, R., Chen, Y., Li, Q., Gong, J., Huang, A., Varghese, Z., Moorhead, J. F., & Ruan, X. Z. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06560.x · Cited by 92
Cao, H., Maeda, K., Görgün, C. Z., Kim, H., Park, S., Shulman, G. I., Kim, J. K., & Hotamışlıgil, G. S. (2006) · Diabetes · doi:10.2337/db05-1496 · Cited by 92
Navarro, L. A., Wree, A., Povero, D., Berk, M. P., Eguchi, A., Ghosh, S., Papouchado, B. G., ERZURUM, S. C., & Feldstein, A. E. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.09.015 · Cited by 92
p38γ and p38δ reprogram liver metabolism by modulating neutrophil infiltration
González‐Terán, B., Matesanz, N., Nikolić, I., Verdugo, M. A., Sreeramkumar, V., Hernández‐Cosido, L., Mora, A., Crainiciuc, G., Sáiz, M. L., Bernardo, E., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201591857 · Cited by 90
Seyhun, E., Malo, A., Schäfer, C., Moskaluk, C. A., Hoffmann, R., Göke, B., & Kubisch, C. H. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00483.2010 · Cited by 77
Hermans, M. P., Ahn, S. A., & Rousseau, M. F. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-88 · Cited by 76
McFadden, J. W., Aja, S. M., Li, Q., Bandaru, V. V. R., Kim, E. K., Haughey, N. J., Kuhajda, F. P., & Ronnett, G. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115642 · Cited by 73
Small-Molecule Inhibitors of PKR Improve Glucose Homeostasis in Obese Diabetic Mice
Nakamura, T., Arduini, A., Baccaro, B., Furuhashi, M., & Hotamışlıgil, G. S. (2013) · Diabetes · doi:10.2337/db13-1019 · Cited by 71
Hadad, N., Burgazliev, O., Elgazar-Carmon, V., Solomonov, Y., Wueest, S., Item, F., Konrad, D., Rudich, A., & Lévy, R. (2013) · Diabetes · doi:10.2337/db12-1300 · Cited by 69
FAT FLUX: enzymes, regulators, and pathophysiology of intracellular lipolysis
Zechner, R. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404846 · Cited by 68
Hsu, B., Chen, Y., Lee, R., Lee, C., Lee, C., & Wang, J. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0568 · Cited by 62
ER Stress as a Trigger for β-Cell Dysfunction and Autoimmunity in Type 1 Diabetes
O’Sullivan-Murphy, B., & Urano, F. (2012) · Diabetes · doi:10.2337/db12-0091 · Cited by 62
Fu, S., Fan, J., Blanco, J., Giménez-Cassina, A., Danial, N. N., Watkins, S. M., & Hotamışlıgil, G. S. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002902 · Cited by 61
Yang, J., Kim, J. T., Jeon, J., Park, H. S., Kang, G. H., Park, K. S., Lee, H. K., Kim, S., & Cho, Y. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013858 · Cited by 60
Erős, G., Varga, G., Váradi, R., Czóbel, M., Kaszaki, J., Ghyczy, M., & Boros, M. (2008) · European Surgical Research · doi:10.1159/000167856 · Cited by 59
Lu, Z., Zhang, X., Li, Y., Lopes-Virella, M. F., & Huang, Y. Q. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.06.016 · Cited by 56
Salles, J., Tardif, N., Landrier, J., Mothe‐Satney, I., Guillet, C., Vaysse, C., Combaret, L., Giraudet, C., Patrac, V., Bertrand‐Michel, J., et al. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.12.001 · Cited by 56
Pro-inflammatory obesity in aged cannabinoid-2 receptor-deficient mice
Schmitz, K., Mangels, N., Häußler, A., Ferreirós, N., Fleming, I., & Tegeder, I. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.169 · Cited by 53
Bao, Y., Lu, Z., Zhou, M., Li, H., Wang, Y., Gao, M., Wei, M., & Jia, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019115 · Cited by 53
Adipocyte fatty acid-binding protein is released from adipocytes by a non-conventional mechanism
Kralisch, S., Ebert, T., Lössner, U., Jeßnitzer, B., Stümvoll, M., & Faßhauer, M. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.232 · Cited by 52
Yoo, H. J., Kim, S., Park, M. S., Choi, H. Y., Yang, S. J., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, D. S., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1473 · Cited by 50
Peng, X., Ju, S., Fang, F., Wang, Y., Fang, K., Cui, X., Liu, C., Li, P., Mao, H. Z., & Teng, G. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00401.2012 · Cited by 49
The Role of TNF-α in Mice with Type 1- and 2- Diabetes
Koulmanda, M., Bhasin, M., Awdeh, Z., Qipo, A., Fan, Z., Hanidziar, D., Putheti, P., Shi, H., Csizuadia, E., Libermann, T. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033254 · Cited by 47
Aksoy, E., Amraoui, Z., Goriely, S., Goldman, M., & Willems, F. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200211)32:11<3040::aid-immu3040>3.0.co;2-m · Cited by 47
Borst, S. E., Lee, Y., Conover, C. F., Shek, E. W., & Bagby, G. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00054.2004 · Cited by 46
Liu, M., Zhou, M., Bao, Y., Xu, Z., Li, H., Zhang, H., Zhu, W., Zhang, J., Xu, A., Wei, M., et al. (2012) · Clinical Science · doi:10.1042/cs20120004 · Cited by 46
FFA4 receptor (GPR120): A hot target for the development of anti-diabetic therapies
Liu, H., Wang, W., Xu, Z., Liu, C., He, D., Du, L.-P., Li, M., Yu, X., & Sun, J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.028 · Cited by 43
Kim, Y.-C., Cho, Y.-K., Lee, W., Kim, H.-J., Park, J., Park, D. I., Sohn, C.-I., Jeon, W.-K., Kim, B.-I., Park, S., et al. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.02.007 · Cited by 42
Ishikawa, K., Takahashi, K., Bujo, H., Hashimoto, N., Yagui, K., & Saito, Y. (2006) · Hormone and Metabolic Research · doi:10.1055/s-2006-954580 · Cited by 40
Borst, S. E., & Bagby, G. J. (2002) · Metabolism · doi:10.1053/meta.2002.34043 · Cited by 36
Gentile, C. L., Wang, D., Pfaffenbach, K. T., Cox, R., Wei, Y., & Pagliassotti, M. J. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0533-3 · Cited by 32
Bouter, B., Geary, N., Langhans, W., & Asarian, L. (2010) · Metabolism · doi:10.1016/j.metabol.2009.11.003 · Cited by 30
Shiratsuchi, A., Ichiki, M., Okamoto, Y., Ueda, N., Sugimoto, N., Takuwa, Y., & Nakanishi, Y. (2008) · The Journal of Biochemistry · doi:10.1093/jb/mvn139 · Cited by 25
SmD3 Regulates Intronic Noncoding RNA Biogenesis
Scruggs, B. S., Michel, C. I., Ory, D. S., & Schaffer, J. E. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00022-12 · Cited by 25
The endoplasmic reticulum as a potential therapeutic target in nonalcoholic fatty liver disease.
Gentile, C. L., & Pagliassotti, M. J. (2008) · PubMed · Cited by 23
New Approaches for Studying Alcoholic Liver Disease
Xu, J., Liu, X., Gao, B., Karin, M., Tsukamoto, H., Brenner, D. A., & Kisseleva, T. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-014-0053-z · Cited by 13
Cited by
The intestinal microbiota fuelling metabolic inflammation
Tilg, H., Zmora, N., Adolph, T. E., & Elinav, E. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0198-4 · Cited by 1,089
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Marra, F., & Svegliati-Baroni, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.014 · Cited by 847
Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease
Smith, R. L., Soeters, M. R., Wüst, R. C. I., & Houtkooper, R. H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00211 · Cited by 787
Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes
Kolb, H., & Martin, S. (2017) · BMC Medicine · doi:10.1186/s12916-017-0901-x · Cited by 717
Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids
Rogero, M., & Calder, P. (2018) · Nutrients · doi:10.3390/nu10040432 · Cited by 706
Metadata
- Authors
- Ertunc, M. E., & Hotamisligil, G. S.
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 57
- Issue
- 12
- Pages
- 2099-2114
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2461706302
- Cited by
- 488
- References
- 244
- FWCI
- 33.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.